PRNewswire - March 13, 2000

Speaking today at the American Academy of Dermatology's 2000 Annual Meeting in San Francisco, dermatologist M. Joyce Rico, MD, deputy chief of staff, VA New York Harbor Health System and associate professor of dermatology at New York University, New York City, NY, discussed the issues surrounding dermatological conditions and appropriate treatments for HIV-infected women.

Dermatologists, who are experts in treating sexually transmitted diseases (STDs), have often observed that common skin conditions like recurring yeast vaginal infections can actually be an early marker for HIV infection. Women and physicians tend to treat the yeast infections without recognizing that recurrent yeast infections can be potentially early markers for HIV. Women who are immune-suppressed often develop severe and treatment-resistant vaginal yeast infections with milky white discharge and white patches on moist surfaces. Oral medications may be required for these yeast infections. A recent study showed that 37 percent of patients who initially had recurrent vaginal yeast infections eventually sought care for HIV.

"Too often patients and their physicians treat a specific incident of an STD or a yeast infection without looking at the overall pattern of these conditions," said Dr. Rico. "We need to focus on the increasing number of cases of HIV in women and be aware that if a woman has specific recurring problems with certain dermatologic conditions, she may be at risk for HIV."

Some skin conditions occur so frequently in HIV-infected women that they are now considered signs of the disease. Herpes zoster (shingles), oral candidiasis (thrush), oral hairy leukoplakia -- an unusual condition that causes small, white, fuzzy patches most often on the tongue, and molluscum contagiosum -- a superficial infection caused by a virus, are among the conditions that often lead dermatologists to suggest an HIV test for patients. Cervical and vaginal secretions are also an important reservoir of HIV. Viral loads (the amount of the virus in the system) can be detected in fluid obtained through cervical discharge.

"Until recently there has not been much attention to the relationship between skin conditions and HIV infection in women," said Dr. Rico. "Women and their physicians need to be aware that complacency is part of the tragedy of this epidemic."

Women acquire the HIV infection most frequently through heterosexual contact. Women infected with sexually transmitted diseases like herpes simplex, syphilis or venereal warts (human papillomavirus or HPV) have an increased risk of also becoming infected with HIV. In one study, 24 percent of HIV-infected women were also infected with three or more HPV types. Since certain types of HPV are also a cause of cervical cancer, HIV-infected women also are at higher risk for cervical cancer due to their compromised immune system. HIV-infected women have a high incidence of cervical cancer and a 50 percent recurrence rate following treatment. While rare, invasive cervical carcinoma is an AIDS-defining illness.

One notable exception in cutaneous diseases between men and women is the low prevalence of Kaposi's sarcoma (KS), a rare form of skin cancer, in women infected with HIV or AIDS. KS, which ranges in size from a pinhead to the size of a large coin, does not hurt or itch. It appears anywhere on the skin or in the mouth as pink, purple, dark red or brown lesions that are often mistaken for insect bites, birthmarks or bruises. This cancer develops in about 15 percent of HIV/AIDS cases overall, with less than 2 percent of those cases developing in the female population.

"Overall, the treatments for these skin conditions are not different for men and women with HIV," noted Dr. Rico. "We've entered an era where people think that there are all kinds of great new drugs so HIV isn't a threat any more. The reality is that there is still a great deal of mortality and morbidity associated with HIV and AIDS. The sooner a woman is diagnosed, the sooner she can get the medical attention she needs. Despite advances in HIV treatment, women infected with HIV are less likely than men to receive appropriate care and follow-up. By paying attention to some dermatological markers, a woman may be able to get the help she needs sooner."

The American Academy of Dermatology, founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of over 13,000 dermatologists worldwide, the Academy is committed to: advancing the science and art of medicine and surgery related to the skin; advocating high standards in clinical practice, education, and research in dermatology; supporting and enhancing patient care; and promoting a lifetime of healthier skin, hair and nails. For more information, contact the AAD at 1-888-462-DERM or http://www.aad.org .

SOURCE American Academy of Dermatology

CONTACT: Missy Gough, 847-240-1734 or e-mail, mgough@aad.org, or Karen Klickmann, 847-240-1735 or e-mail, kklickmann@aad.org, both of American Academy of Dermatology/

Web Site: http://www.aad.org /
000313
PR000318

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .